<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">KETOPROFEN</span><br/>(kee-toe-proe'fen)<br/><span class="topboxtradename">Actron, </span><span class="topboxtradename">Orudis, </span><span class="topboxtradename">Orudis KT, </span><span class="topboxtradename">Oruvail, </span><span class="topboxtradename">Rhodis A<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">analgesic</span>; <span class="classification">antipyretic</span>; <span class="classification">nsaid</span><br/><b>Prototype: </b>Ibuprofen<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>12.5 mg, 25 mg, 50 mg, 75 mg capsules; 100 mg, 150 mg, 200 mg sustained release capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Nonsteroidal antiinflammatory drug (NSAID) structurally related to ibuprofen. Analgesic potency matches that of indomethacin
         and is stronger than that of aspirin. Inhibits platelet aggregation and prolongs bleeding time. Has fewer adverse GI effects
         than aspirin.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Has analgesic, antiinflammatory, and antiplatelet properties.</p>
<h1><a name="uses">Uses</a></h1>
<p>Acute or long-term treatment of rheumatoid arthritis and osteoarthritis; primary dysmenorrhea; headache; symptomatic relief
         of postoperative, dental, and postpartum pain; visceral pain associated with cancer.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Reiter's syndrome, juvenile arthritis, acute gouty arthritis, biliary pain, renal colic.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Patient in whom aspirin or another NSAID induces asthma, urticaria, bronchospasm, severe rhinitis, shock. Safety during pregnancy
         (category B), lactation, or in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>History of GI disease, GI bleeding, active ulcer; renal or hepatic impairment, patient who may be adversely affected by prolongation
         of bleeding time; heart failure, hypertension; patient receiving diuretics; geriatric patient; myasthenia gravis.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Inflammatory Disease</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 75 mg t.i.d. or 50 mg q.i.d. (max: 300 mg/d) or 200 mg sustained release q.d.<br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> Start with 25 mg q.i.d., may also start with 50 mg t.i.d.<br/><br/><span class="indicationtitle">Mild to Moderate Pain, Dysmenorrhea</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 12.550 mg q68h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Do not crush.</li>
<li>Give with food, milk, or prescribed antacid to reduce GI irritation.</li>
<li>Store drug at 15°30° C (59°86° F) in tightly closed, light-resistant container unless otherwise
            directed.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Trouble in sleeping, nervousness, <span class="speceff-common">headache,</span> dizziness; depression, drowsiness, confusion, migraine, vertigo. <span class="typehead">CV:</span> Peripheral edema, palpitations, hypertension, tachycardia. <span class="typehead">Special Senses:</span> Visual disturbances, conjunctivitis, eye pain, retinal hemorrhage, pigmentation changes; Dry nose or throat, tinnitus, hearing
      impairment. <span class="typehead">GI:</span> <span class="speceff-common">Dyspepsia,</span> <span class="speceff-life">drug-induced peptic ulcer, GI bleeding</span>, nausea, vomiting, diarrhea, constipation, flatulence, stomach pain, anorexia, dry mouth, gingivitis, rectal burning and
      hemorrhage, melena, jaundice, elevated ALT, AST. <span class="typehead">Hematologic:</span> Prolonged bleeding time, anemia, purpura, <span class="speceff-life">agranulocytosis</span>, thrombocytosis. <span class="typehead">Urogenital:</span> Gynecomastia, changes in libido, urinary tract irritation (dysuria, frequency/urgency), renal impairment. <span class="typehead">Respiratory:</span> <span class="speceff-life">Laryngospasm, bronchospasm, laryngeal edema</span>, pharyngitis. <span class="typehead">Skin:</span> Rash, pruritus, urticaria, erythema, photosensitivity. <span class="typehead">Endocrine:</span> Aggravation of diabetes mellitus. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <span class="classification">oral anticoagulants</span>, <b>heparin</b> may prolong bleeding time; may increase <b>lithium</b> toxicity; may increase <b>methotrexate</b> toxicity. <span class="typehead">Herbal:</span> <b>Feverfew,</b> <b>garlic,</b> <b>ginger,</b> <b>ginkgo</b> increases bleeding potential. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 12 h. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Duration:</span> 46 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted primarily in urine, with some biliary excretion. <span class="typehead">Half-Life:</span> 1.14 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Monitor baseline and periodic evaluations of hemoglobin, renal and hepatic function.</li>
<li>Monitor for and report tinnitus, hearing impairment, and visual disturbance, especially during prolonged or high-dose therapy.</li>
<li>Monitor for S&amp;S of GI ulceration (e.g., stool for occult blood, persistent indigestion).</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report promptly signs of jaundice (see Appendix F) as well as the following: blurred vision, tinnitus, urinary urgency or
            frequency, unexplained bleeding, weight gain with edema.
         </li>
<li> 							Note: Possible CNS adverse effects (e.g., light-headedness, dizziness, drowsiness). 						</li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li> 							Note: Alcohol, aspirin, or other <small>NSAID</small>s may increase risk of GI ulceration and bleeding tendencies and therefore should be avoided. 						
         </li>
<li>Tell dentist or surgeon that you are taking ketoprofen.</li>
<li>Do not breast feed infants while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>